Cargando…

Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes

Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT interval of the patient’s electrocardiogram. The syndrome is associated with increased risk of arrhythmia and sudden cardiac death and can arise from a number of ion channel mutations. Cardiomyocytes derived fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jæger, Karoline Horgmo, Wall, Samuel, Tveito, Aslak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909705/ https://www.ncbi.nlm.nih.gov/pubmed/33591962 http://dx.doi.org/10.1371/journal.pcbi.1008089

Ejemplares similares

Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems
por: Tveito, Aslak, et al.
Publicado: (2018)

Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems
por: Jæger, Karoline Horgmo, et al.
Publicado: (2020)

Computational translation of drug effects from animal experiments to human ventricular myocytes
por: Tveito, Aslak, et al.
Publicado: (2020)

Deriving the Bidomain Model of Cardiac Electrophysiology From a Cell-Based Model; Properties and Comparisons
por: Jæger, Karoline Horgmo, et al.
Publicado: (2022)

Identifying Drug Response by Combining Measurements of the Membrane Potential, the Cytosolic Calcium Concentration, and the Extracellular Potential in Microphysiological Systems
por: Jæger, Karoline Horgmo, et al.
Publicado: (2021)

Efficient, cell-based simulations of cardiac electrophysiology; The Kirchhoff Network Model (KNM)
por: Jæger, Karoline Horgmo, et al.
Publicado: (2023)

The simplified Kirchhoff network model (SKNM): a cell-based reaction–diffusion model of excitable tissue
por: Jæger, Karoline Horgmo, et al.
Publicado: (2023)

A computational method for identifying an optimal combination of existing drugs to repair the action potentials of SQT1 ventricular myocytes
por: Jæger, Karoline Horgmo, et al.
Publicado: (2021)

Properties of cardiac conduction in a cell-based computational model
por: Jæger, Karoline Horgmo, et al.
Publicado: (2019)

Arrhythmogenic influence of mutations in a myocyte-based computational model of the pulmonary vein sleeve
por: Jæger, Karoline Horgmo, et al.
Publicado: (2022)

Nano-scale solution of the Poisson-Nernst-Planck (PNP) equations in a fraction of two neighboring cells reveals the magnitude of intercellular electrochemical waves
por: Jæger, Karoline Horgmo, et al.
Publicado: (2023)

From Millimeters to Micrometers; Re-introducing Myocytes in Models of Cardiac Electrophysiology
por: Jæger, Karoline Horgmo, et al.
Publicado: (2021)

Computing characterizations of drugs for ion channels and receptors using Markov models
por: Tveito, Aslak, et al.
Publicado: (2016)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Conversations about challenges in computing
por: Bruaset, Are, et al.
Publicado: (2013)

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Introduction to partial differential equations: a computational approach
por: Tveito, Aslak, et al.
Publicado: (1998)

Advanced topics in computational partial differential equations: numerical methods and diffpack programming
por: Langtangen, Hans, et al.
Publicado: (2003)

An Evaluation of the Accuracy of Classical Models for Computing the Membrane Potential and Extracellular Potential for Neurons
por: Tveito, Aslak, et al.
Publicado: (2017)

“Thorough QT/QTc in a Dish”: Can Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Predict Thorough QT Outcomes?
por: Vargas, Hugo M.
Publicado: (2019)

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Sala, Luca, et al.
Publicado: (2019)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Huang, Mengying, et al.
Publicado: (2021)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Elements of Scientific Computing
por: Tveito, Aslak, et al.
Publicado: (2010)

Simula Research Laboratory
por: Tveito, Aslak
Publicado: (2010)

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
por: Matsa, Elena, et al.
Publicado: (2011)

Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs
por: Blinova, Ksenia, et al.
Publicado: (2019)

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2021)

Computational analysis of the electromechanical consequences of short QT syndrome
por: Huang, Christopher L.-H.
Publicado: (2015)

KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation
por: Song, Yuanxiu, et al.
Publicado: (2022)

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
por: Shinozawa, Tadahiro, et al.
Publicado: (2017)

QT Assessment in Early Drug Development: The Long and the Short of It
por: Lester, Robert M., et al.
Publicado: (2019)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Song, Yongfei, et al.
Publicado: (2022)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Lan, Huan, et al.
Publicado: (2020)

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients
por: Fatima, Azra, et al.
Publicado: (2013)

Numerical methods and software tools in industrial mathematics
por: D√¶hlen, Morten, et al.
Publicado: (1997)

Computing the electrical activity in the heart
por: Sundnes, Joakim, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_everiqk4hu8ggu6d4g3veo9h5j